Chapter 40: Cardiac Glycosides, Antianginals & Antiarrhythmics

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive.

Today we are doing something a little different.

Usually we take a really broad topic and, you know, we try to narrow it down, looking for that one little golden nugget of truth.

Today we're flipping that.

We are taking a narrow topic, chapter 40 of pharmacology,

a patient -centered nursing process approach, the 12th edition, and we are just blowing it up.

We are looking at the cardiovascular system.

And not just the system in general.

We are looking at the heavy artillery, the big three drug categories that, you know, keep the heart beating or stop it from beating too fast or fix it when the plumbing completely fails.

We're talking cardiac glycosides, antianginals, and anti -dysrhythmics.

This is really high -stakes material.

I mean, if you're a nursing student, this is the unit that usually makes people sweat.

Oh, for sure.

And if you're a practicing nurse, this is probably the refresher you need because, let's be honest, the science changes and the mechanism of action, the why, sometimes gets a little lost in the daily grind of just handing out pills.

It absolutely does.

And the margin for error with these drugs is it's just razor thin.

We aren't talking about, you know, multivitamins or some mild pain relievers here.

We're talking about medications where the difference between a therapeutic dose and a lethal dose is it's microscopic.

So, here is our mission for this deep dive.

We are going to deconstruct unit 12, and we're not going to just, you know, read the bold print.

We are going to look at the mechanism.

Why does the heart fail?

Why do we give a drug that's made from a poisonous flower to fix it?

And why does fixing one problem often create a completely different, equally dangerous one?

Exactly.

So, we'll start with the physiology,

the plumbing and the wiring, so to speak.

Then we'll break down heart failure and the big one, Dagoxin.

We'll move on to angina and the whole supply and demand economy of the heart.

And the really complex stuff,

dysrhythmias.

And then finally, we'll kind of test ourselves with a case study to see if we can actually spot a patient in crisis before it's way too late.

All right.

Let's start at the beginning, the physiology.

You often hear the heart described as a pump, which is, I mean, it's accurate, but it feels a bit reductive, you know.

It is a pump, but you're right.

It's a pump that powers two completely separate loops at the same time.

You have to visualize this clearly or the drugs just aren't going to make sense.

Okay.

So, you have the right side of the heart.

That's the low pressure cistern.

It takes all the trash, the deoxygenated blood, the CO2, all the metabolic waste, and it just gently pushes it over to the lungs.

That's the pulmonary circulation.

Yeah, that's pulmonary circulation.

Correct.

Then the lungs do their magic.

They oxygenate the blood and they send it over to the left side.

Now, the left side,

that's the high pressure system.

Right.

The left ventricle is the heavyweight champion of the body.

It has these thick, thick muscular walls, the myocardium, because it had to generate enough force to shove that fluid through the aorta and all the way down to your toes against gravity and resistance.

That myocardium is so crucial.

The text really makes a point that the ventricles are significantly thicker than the atria.

Oh, they have to be.

The atria, they're like reception rooms.

They just receive the blood.

The ventricles are the engine room.

They do the actual ejection.

Okay.

When we talk about heart failure later, it's usually that ventricular muscle that's the part that's giving up.

When we measure how well that champion is performing, we talk about cardiac output.

The text gives us a formula here.

CO equals stroke volume times heart rate.

It's a simple multiplication, but it tells you literally everything.

CO equals SV times HR.

You've got the rate, how fast are we going?

Yeah.

And you've got the stroke volume, how much fluid are we actually moving with each squeeze?

Okay.

In healthy adults, you're moving, what, four to eight liters of blood every single minute.

Wow.

That's like moving four of those big two -liter soda bottles worth of fluid through your body every 60 seconds.

It's an incredible amount of work.

Now the heart rate part is,

that's pretty easy to understand, but the stroke volume, that seems to be where all the pharmacology really comes into play.

The text breaks this down into three components.

It calls them the holy trinity of cardiac mechanics,

preload,

contractility, and afterload.

Yes.

And if you take one thing away from this whole physiology review,

let it be these three terms.

Okay.

Because almost every single drug we're going to discuss today is just a tool to manipulate one of these three variables.

That's all it is.

All right.

Let's tackle preload first.

The text calls it blood flow force that stretches the ventricle.

Okay.

Think of a slingshot or a balloon.

Preload is the stress.

It's stress.

Before the heart squeezes, it fills up with blood.

That volume of blood stretches the muscle fibers.

And up to a point, the more you stretch that rubber band, the harder it snaps back.

That's Starling's law.

So if you increase the volume coming in, you increase the output.

Correct.

Until you overstretch the balloon and it just gets floppy.

Which is exactly precisely what happens in heart failure.

But under normal circumstances, preload is just the fill.

It's the volume at the end of diastole, right before the squeeze.

Okay.

Got it.

Then we have contractility.

This is the quality of the muscle itself.

So independent of how much blood is actually

How hard can that muscle fiber squeeze?

It's the horsepower of the engine.

If you have a strong engine, high contractility, you get a really powerful ejection.

If the engine is weak, the blood just kind of sloshes around in there.

And finally, afterload.

This is the one that I think confuses people the most.

It is.

Afterload is just resistance.

Imagine you were trying to push open a really heavy door.

Okay.

The weight of that door is the afterload.

For the heart, the door is the aortic valve and all the pressure in the arteries beyond it.

So if you have high blood pressure or your arteries are clamped shut, vasoconstriction, that door is incredibly heavy.

The heart has to work overtime just to crack it open.

So logically then, if we want to help a failing heart, we can either make the muscle stronger, which is contractility, or we can make the door lighter, reduce the afterload.

Or we can reduce the amount of blood filling the balloon so it doesn't overstretch in the there, just manipulating those three levers.

Before we get to the drugs, though, we have to mention the electrical system, the wiring.

Right.

Because without the spark, the pump is just a lump of meat.

The conduction system.

Yeah.

Yeah, the heart is really unique because it generates its own electricity.

It doesn't need the brain to tell it to beat.

It has its own corporate hierarchy.

And the CEO is the SA node?

The sinoatrial node.

It's high up in the right atrium.

It sets the pace normally at 60 to 80 beats per minute.

If the CEO is healthy, everything runs smoothly.

It fires the atria contract, the signal moves down.

But what if the CEO has a heart attack?

Or, you know, just calls in sick?

Middle manager takes over.

That's the AV node.

But the AV node is slower.

It can only drive the heart at, say, 40 to 60 beats per minute.

It'll keep you alive, but you're definitely not running any marathons.

It's survival mode.

And if the middle manager fails, too?

Then you're down to the interns.

The bundle of his and the Burkinje fibers deep in the ventricles, they fire at a paltry 30 to 40 beats per minute.

Wow.

That is barely compatible with life.

It's a desperate last ditch backup system to keep blood moving to the brain, but just barely.

And on top of this internal hierarchy, we have the autonomic nervous system sort of holding the remote control.

Right.

You've got the sympathetic sister, which is the accelerator.

It dumps catecholamines like adrenaline to speed up the rate and increase the squeeze.

Fight or flight.

And then you have the parasympathetic system, which works through the vagus nerve, and that's the brake.

It slows everything down.

OK, so we have the plumbing, the levers, and the hierarchy.

Let's break it.

Section two,

heart failure.

Right.

Heart failure is a progressive condition.

The text defines it really simply.

The heart and kind of counterintuitively gets bigger.

Cardiomegaly.

It hypertrophies to try and compensate for being weak, but it just becomes this big, floppy, inefficient pump.

And we distinguish between left -sided and right -sided failure.

This feels really important for the clinical assessment.

Oh, it's vital.

Think about that plumbing loop again.

If the left ventricle, the main pump fails, it can't push blood forward into the body.

OK.

So where does the fluid go?

It backs up.

And where did it just come from?

The lungs.

The lungs.

So left -sided failure means fluid in the lungs.

Dyspnea, crackles on auscultation, shortness of breath, L for left, L for lungs.

Precisely.

Now, if the right ventricle fails, it can't push blood forward to the lungs, so it backs up into the venous system of the body.

Into the periphery.

Exactly.

Your peripheral edema, swollen ankles, swollen liver.

You can see the jugular vein distension in the neck.

The fluid has nowhere else to go but into the tissues.

The text mentions a specific lab test to diagnose this, because if a patient comes in wheezing, I mean, it could be asthma, it could be pneumonia, or it could be left -sided heart failure.

How do we know for sure?

We check the BNP, brain natriuretic peptide.

Which is just a terrible name because it comes from the heart, not the brain.

It is a terrible name.

It was discovered in brain tissue first, but yes, it's secreted by the heart ventricles.

And here's the mechanism.

When that heart muscle is overstretched, when that preload is way too high and the balloon is about to pop, the heart cells scream for help by releasing BNP.

So it's a distress signal.

It's a biochemical distress signal.

So high BNP means a frantic heart.

What are the numbers we need to look for on the lab report?

Okay, so you want to be under 100 picograms per milliliter.

That's happy.

If you are Over 400, that's almost certainly heart failure.

It's highly specific.

There's a caveat in the text for older women, though.

Yes, it's a good point.

The text notes that generally women over 65 can have a naturally higher baseline.

So, you know, 80 -year -old woman might sit at 160 normally.

Right.

But a marked elevation is still the gold standard for diagnosis.

A jump to 400, 500, 1 ,000.

That's the hard talking.

Okay, so the patient is in heart failure.

The pump is weak.

We need to strengthen it.

Enter the cardiac glycosides, specifically digoxin.

Digoxin is a dinosaur.

And I mean that with the utmost respect.

Right.

We've been using it since 1200 CE, derived from the foxglove plant.

It's one of the oldest drugs in the pharmacopeia.

It's not the first line drug anymore.

We usually start with diuretics and ACE inhibitors now.

But for symptom management, it is still a powerhouse.

So how does it actually work?

The text lists three tropic effects.

Let's break down the cellular mechanism first.

To understand digoxin, you have to look at the sodium -potassium pump that's in all the cells.

Digoxin inhibits that pump.

It gums it up.

Okay.

This causes a chain reaction that ultimately ends up trapping calcium inside the heart muscle cells.

And calcium is the key to contraction, right?

Calcium is the key to contraction.

More calcium means a harder squeeze.

That's the positive inotropic effect.

It increases myocardial contractility.

Stroke volume goes up.

The pump gets stronger.

But it also affects the electrical system.

It does.

It stimulates the vagus nerve, which, remember, acts as a break.

That gives it a negative chronotropic effect.

It slows the heart rate.

And it has a negative dramatropic effect.

It slows the conduction of the electrical signal through the AV node.

So in plain English, digoxin makes the heart beat stronger, but slower and more deliberately.

That's it.

Which is perfect for a failing heart.

It gives the ventricle more time to fill up because it's beating slower.

And then it empties it more completely because it's squeezing stronger.

Efficiency just skyrockets.

But digoxin is famous or maybe infamous for being dangerous.

The Narrow Therapeutic Index.

It's incredibly narrow.

For heart failure, we want the blood level to be between 0 .5 and 1 .0 nanograms per milliliter.

Anything over 2 .0 is considered toxic.

And toxicity isn't just oops, I feel a little bad.

It's life threatening.

It is.

Absolutely.

And the symptoms are, they're bizarre.

You get the standard nausea and vomiting.

That's the brainstem being irritated.

You get bradycardia.

The heart's slowing down way too much.

But the hallmark sign,

it's visual.

The halos.

The halos.

Yellow, green or white halos around lights.

It's almost psychedelic.

If a patient tells you the lights look like a Van Gogh painting, you need to check their digoxin level immediately.

That is the brain reacting to the toxicity.

Now we have to talk about the potassium connection.

This is the mechanism that every single nursing student gets quizzed on.

Why does low potassium cause digoxin toxicity?

Okay, this is a competitive inhibition issue.

Imagine the receptor site on the heart muscle is a parking spot.

Okay, a parking spot.

Normally potassium parks there.

Digoxin also wants to park there.

They're in direct competition for the same space.

So they're fighting for the spot.

They're fighting for the spot.

Now, if you have hypokalemia there are lots of empty parking spots.

Potassium isn't there to defend its territory.

So digoxin just floods in and binds to everything.

You essentially get a massive overdose of the drugs effect even if the dose in the pill was totally normal.

And why is this such a common scenario?

Because heart failure patients are almost always on diuretics.

Exactly.

We give them furosemide, which is Lasix, to pee out all that extra fluid.

But Lasix doesn't make you pee out water.

It makes you pee out potassium too.

So we create the hypokalemia that then makes the digoxin toxic.

It's a perfect storm.

So if you are the nurse, what are you doing before you hand that little pill to the patient?

You are checking two things non -negotiable.

First, the apical pulse.

You listen to the heart itself with a stethoscope for a full 60 seconds.

A full minute.

A full minute.

If it's under 60 beats per minute, you hold the drug.

You do not want to slow a slow heart.

Second, you check the most recent potassium level.

If it's low, you don't give the digoxin until you've talked to the doctor and you've fixed the electrolytes.

And if they are already toxic, what's the antidote?

It's digoxin immune fab.

The grand name is Digibind.

It's basically an antibody that hunts down digoxin in the blood, binds it up, and allows the body to excrete it.

It works really quickly to reverse the life -threatening effects.

Before we move off heart failure, the text mentions a few other drugs.

It's not just digoxin anymore.

Let's touch on the phosphatid esterase inhibitors.

It was milirhenone.

Milirhenone is an ICU drug.

It's a positive inotrope, so stronger squeeze, but it also vasodilates.

We sometimes call it an inodilator.

Inodilator.

Okay.

It's used for acute heart failure when digoxin just isn't cutting it.

But it's IV only, very short -term, like 48 to 72 hours max.

Yeah.

It's a bridge therapy, not a long -term solution.

Then there are the ACE inhibitors and ARBs, which are pretty standard for reducing the workload.

And there are two newer developments worth noting.

First, a drug called Bid -Dil.

Bid -Dil is a fascinating case study in pharmacogenomics.

It's a combination of two vasodilators, hydrolazine and isosorbidinitrate.

The clinical trials showed it didn't work significantly better than a placebo in the general population, but it had a profound significant benefit specifically in patients who identified as African -American.

Wow.

It became the first drug FDA approved specifically for a single racial group to address the statistical disparity we see in heart failure outcomes.

And secondly, the SGLT -2 inhibitors, like Empaglifluzin, Dapiglifluzin.

These are diabetes drugs?

Why are they in the heart failure chapter?

This was one of those happy accidents of science.

They were designed to help diabetics pee out extra sugar, but the large -scale trials show that they also helped patients pee out sodium in a way that significantly protected the heart.

So it's a cardiac benefit.

A huge one.

Now, they are becoming a standard of care for heart failure, even if the patient isn't diabetic at all.

Just.

You got to watch out for hypoglycemia if you're using them.

Correct.

That and urinary tract infections, since you're essentially creating a sugary environment down there.

One less note on safety herbal interactions.

The text has a whole box on this.

Yes, and this is important.

Ginseng is dangerous here.

It can falsely elevate the digoxin levels on the lab test, making you think someone is toxic when they're not, or vice versa.

St.

John's Wort creates the opposite problem.

It revs up the liver and chews up the drug too fast so you get no effect.

And things like licorice can act like a diuretic and waste potassium, which puts you right back at risk for toxicity.

So the takeaway is, always ask your patients what teas and supplements they're taking.

Let's shift gears.

Section three, angina pectoris.

Chest pain.

But let's define it physiologically.

Angina is a supply and demand problem.

That's all it is.

The heart muscle, the myocardium, demands oxygen to function.

The coronary arteries supply it with oxygenated blood.

If demand exceeds supply, the muscle screams.

That scream is angina.

And the text distinguishes three types.

Classic, unstable, and variant.

Classic or stable angina is predictable.

You run for the bus, your heart rate goes up, demand for oxygen goes up, supply can't match it, you get pain, you stop running, demand goes down, the pain goes away.

It follows a very clear pattern.

Unstable angina sounds much, much scarier.

It is.

It's also called preinfarction angina, which tells you everything you need to know.

Yeah.

It happens at rest, it's unpredictable, the pain is severe, and it's getting worse.

This is usually a sign that a plaque has ruptured inside an artery and heart attack is imminent.

This is medical emergency.

911.

And variant angina.

Also called Prince metals.

This one is weird.

It's caused by a spasm of the coronary artery, not necessarily a blockage from plaque.

A muscle cramp.

It's a muscle cramp of the artery wall.

It often happens at night at rest.

So how do we fix this supplied mand imbalance?

We have three main drug groups, nitrates, beta blockers, and calcium channel blockers.

Let's start with the classic,

the nitrates, nitroglycerin.

The oldest and the best nitrates are powerful vasodilators.

They relax the smooth muscle in the veins and arteries.

Okay, but how does like relaxing a vein in my leg help the pain in my chest?

It goes right back to preload.

If you dilate the big veins in your legs and the rest of your body, blood pools there.

Less blood returns to the heart.

If less blood returns, the heart doesn't have to stretch as much or pump as hard.

The preload drops, oxygen demand plummets, the pain stops.

It effectively puts the heart on a little vacation.

It also dilates the coronary arteries directly too, right?

It does, which helps the supply side of the equation.

But the main effect, the most powerful effect, is reducing the workload by trapping blood out in the periphery.

Everyone knows that little white tablet under the tongue, a sublingual nitrate.

What is the protocol here?

It's the rule of three.

If you have chest pain, the first thing you do is sit down.

Sit down.

Then you take one pill sublingually.

It should sting or fizz a little.

That means it's fresh.

You wait five minutes.

If the pain is gone, great.

If the pain is not gone, or it's worse, you call 911 immediately.

Immediately before the second pill.

Yes.

Call 911.

Then you can take a second pill, wait another five minutes, you can take a third.

But do not wait to call for help.

Unrelieved chest pain is a heart attack until proven otherwise.

And why is sitting down so important?

Because when you take a massive vasodilator, your blood pressure is going to plummet.

It has to.

If you are standing up, you will hit the floor.

Orthostatic hypotension is almost guaranteed.

And the headache.

Everyone talks about the headache.

The nitro headache is legendary.

It's caused by the vasodilation of the cerebral vessels in your brain.

It is throbbing and it can be intense.

But, and this is a critical teaching point for the nurse,

it means the drug is working.

Right.

Don't stop taking it because of the headache.

Take some acetaminophen, some Tylenol for the headache, but keep taking the nitro.

There's a crucial safety warning in here regarding men's health medications.

This is a do not pass go, do not collect $200 situation.

If a patient has taken a phosphatidase V inhibitor, that's drugs like sildenafil, which is Viagra, or didalafil, Cialis, within the last 24 to 48 hours, they cannot have nitroglycerin.

Why not?

They both lower blood pressure through very similar pathways.

You combine them and you cause a catastrophic, irreversible drop in blood pressure.

The patient can code and die.

It is an absolute, 100 % contraindication.

Let's talk about the nitro patch for a second.

The transdermal nitrolycerin.

It's great for prevention, for long -term management, but the body gets used to it very, very quickly.

We call it tolerance.

Okay.

If you leave the patch on 24 hours a day, by the end of the day, it just stops working.

The receptors are saturated.

So you need a washout period.

You need a washout period, yes.

The stand -alone practice is to take the patch off at night.

Give the patient an 8 to 12 -hour nitrate -free interval while they sleep.

This resets the receptors so the patch will work again the next morning.

Moving to the second group for angina, beta blockers.

We talked about the sympathetic nervous system being the accelerator, right?

Beta blockers basically cut the fuel line to that accelerator.

They block the beta -1 receptors in the heart.

Heart rate goes down.

Contractility goes down.

Oxygen demand goes down.

They are the chill pill for the heart.

That's a great way to put it.

They are fantastic for spable angina, but they have a dark side.

If you stop them abruptly, you get a rebound effect.

Rebound.

The heart has been suppressed for so long that it upregulates its receptors.

It grows more of them, trying to catch a signal.

If you suddenly pull the drug away, all those new receptors get flooded with adrenaline and the heart goes into overdrive.

You can actually cause a heart attack by stopping the medication too fast.

So you have to taper.

You must taper them over a week or two.

Never stop cold turkey.

And we need to watch out for the non -selective ones.

Right.

Beta -1 is heart.

Beta -2 is lungs.

A selective drug like metaprolol mainly hits the heart.

A non -selective one like propranolol hits both.

If you block the beta -2 receptors in the lungs, you cause bronchoconstriction.

So if your patient has asthma or COPD, giving them propranolol could trigger a full -blind respiratory crisis.

Correct.

For those patients, you want to stick to the selective ones.

It's much safer.

And the third group, calcium channel blockers.

The CCBs.

The rapamil, diltiasum, nephetapine.

It's simple.

Calcium is required for muscle contraction.

If you block the calcium channel, the muscle relaxes.

Okay.

This relaxes the peripheral arteries, which lowers afterload, and it also relaxes the coronary arteries.

So these are the drug of choice for that variant, that Prince metal angina we mentioned, right?

The spasms.

Absolutely, because they directly relax that spasm.

Beta blockers can actually make the spasms worse sometimes.

So for variant angina, CCBs are definitely the way to go.

Okay.

We've managed the failure, we've managed the pain, now we have to manage the rhythm.

Section 4.

Cardiac dysrhythmias.

And this is probably the most complex part of the chapter.

A dysrhythmia is any deviation from the normal electrical rhythm.

Too fast is tachycardia, too slow is bradycardia, or just plain chaotic is fibrillation.

And the drugs we use to treat them, the antidisrhythmics, have this really scary irony built right into them.

The pro -dysrhythmic effect.

It's the cruel joke of cardiology.

Almost every single drug used to treat an arrhythmia can, under the right conditions, cause a new, different, and potentially fatal arrhythmia.

So treating a little skip in the beat might cause the heart to just stop altogether.

It's a risk versus benefit calculation every single time.

And that's why we monitor these patients on a continuous ECG when we're starting these meds.

You do not send someone home on a new antidisrhythmic without watching them closely first.

The text groups these into four classes based on the Vaughan Williams classification.

Let's start with class one, sodium channel blockers.

Okay, imagine the nerve impulse is a wave moving down a wire.

Sodium rushing into the cell is what starts that wave.

Class I drugs block that sodium.

They slow down the speed of the conduction.

They flatten the wave.

We have subtypes A, B, and C.

Let's maybe take a highlight from each.

Okay, class IA has quinidine.

It's the grandfather of the group.

But it has miserable side effects, diarrhea, nausea, something called synchronism, which is ringing in the ears.

It also causes significant hypotension.

We just don't use it much anymore because the newer drugs are cleaner.

And class IB gives us lidocaine.

Right.

Most people think of lidocaine as the stuff the dentist injects to numb your gum.

But when you give it intravenously, it numbs the heart.

It's used for acute ventricular dysrhythmias.

But because it numbs nerves, if you get too much, you get confusion, slurred speech, and eventually seizures.

It crosses the blood -brain barrier very easily.

And class SE?

Fleconide.

It's very potent.

It's usually reserved for life -threatening ventricular dysrhythmias, but it has a very high pro -dysrhythmic potential itself.

It's a big gun for big problems.

Class II is beta blockers again.

Same mechanism as before.

Slow the heart rate.

Stabilize the rhythm by decreasing what we call automaticity, the tendency of cells to fire on their own.

Agus futol and esmolol are common here.

Class III is the heavy hitters.

Drugs that prolong repolarization.

This is where we find amiodarone.

Amiodarone is a sledgehammer of cardiac drugs.

It is used for life -threatening ventricular dysrhythmias that don't respond to anything else.

But it is a very dirty drug.

It goes everywhere in the body, and it stays there for a very, very long time.

It has a crazy long half -life rate.

Weeks to months.

You could stop taking it today and still have it in your system next month.

Because of that, it has time to be toxic to the liver, the thyroid, and most dangerously, the lungs.

The lungs.

Pulmonary toxicity fibrosis of the lungs is the big black box warning.

If your patient on amiodarone develops a new cough or shortness of breath, you investigate immediately.

And it can turn your skin blue.

It can.

A blue -gray discoloration of the photosensitivity reaction, we call it the blue man syndrome.

It's cosmetic, but it's obviously very disturbing for the patient.

Also in Class III, we have adenosine.

This drug is famous in the ER.

Adenosine is for something called PSVT paroxysmal supraventricular tachycardia.

The heart is just racing, maybe 200 beats per minute, out of nowhere.

Adenosine is the control -alt -delete for the heart.

How do you give it?

You have to slam it.

IV, push as fast as you possibly can, followed immediately by a fast saline flush.

Its half -life is less than 10 -7.

If you give it slowly,

the blood just eats it up before it even reaches the heart.

And what happens when it hits?

A systole.

The heart stops.

On the monitor, you see a flat line for a few seconds.

It's terrifying for the patient.

They feel like they've been kicked in the chest or that they're dying.

And then, hopefully, the SA node kicks back in and restarts the rhythm at a normal, slower rate.

That takes nerves of steel for the nurse.

It does.

You have to warn the patient beforehand.

You say, you're going to feel terrible for about five seconds, and then it'll be over.

But it's incredibly effective.

And finally, clastor, calcium channel blockers again.

Right, rapamil and diltiasm.

They slow conduction through the AV node, just like they do for angina.

They're great for slowing down rapid atrial rhythms, like atrial fibrillation.

But you never,

ever use them if the patient already has an AV block or significant heart failure, because it can make the pump too weak to function.

Okay, that's the pharmacology.

It's a lot.

Now, let's see if we can actually use it.

Section five, the clinical judgment case study.

This is an unfolding case study right from the text.

So we have a 64 -year -old female patient.

She has a known history of heart failure.

Okay, let's look at her home medications.

She has taken digoxin, 0 .25 milligrams daily,

furosemide or Lasix, 40 milligrams daily.

Okay.

And potassium chloride, KCL, 20 mil equivalents daily.

And that is the classic heart failure cocktail.

The digoxin for the squeeze, the Lasix to get rid of the fluid, and the potassium to replace with the Lasix makes you lose.

It's a balanced ecosystem.

But here's the situation.

She comes into the clinic complaining of the flu.

She's been sick for three days, anorexia, nausea, vomiting, diarrhea.

And she tells the nurse, I stopped taking that big potassium pill because it upsets my stomach.

And since I was already vomiting, I didn't want to make it worse.

Stop right there.

Red lights should be flashing in your head.

Alarms should be going off.

What are the cues?

What are the first things you're thinking?

Okay, one,

she stopped the potassium.

So she is almost certainly hypokalemic.

Two, she is vomiting and has diarrhea, which loses more potassium.

Three,

she is still taking the digoxin.

Remember the parking lot.

Exactly.

Low potassium means empty parking spots.

Yeah.

The digoxin is parking everywhere.

She is toxic.

And the flu symptoms.

The nausea, the vomiting, the anorexia.

That isn't the flu.

Those are the classic early signs of digitalis toxicity.

She's been poisoning herself for three days.

We check her vitals.

Pulse is 90 and it's irregular.

She feels weak and lightheaded.

The muscle weakness is from the low potassium.

The lightheadedness and the irregular pulse are from the poor cardiac output and the digoxin messing with the heart's conduction.

The labs come back.

Her potassium is 3 .0 in EQL.

Low.

Normal is 3 .5 to 5 .0.

So she's definitely hypokalemic.

Her digoxin level is 3 .0 and GMO.

Toxic.

Remember, anything over 2 .0 is toxic.

She's deep in the danger zone.

And her BMP is a thousand pGML.

So her heart failure is screaming.

It's completely decompensated.

She is in crisis.

So how do we fix this?

What is the priority?

What's action number one?

We have to reverse the toxicity and fix the electrolytes.

Step one, administer digoxin immune fab, the Digibind.

We have to get that drug out of her system.

It will bind up the free digoxin so it can't affect the heart anymore.

And step two.

Replace the potassium.

But you have to do it carefully.

You can't just push IV potassium fast or you'll stop the heart the other way from hyperkalemia.

It has to be a slow, controlled infusion or oral replacement if she can tolerate it now.

The text also mentions some ineffective actions.

Things you shouldn't do.

Right.

Don't give her antibiotics like ceftriaxone.

She doesn't have a bacterial infection.

Don't just give her anti -nausea meds without fixing the root cause of the nausea.

And for goodness sake, don't give her more digoxin.

Once she's stable, what is the teaching moment here?

Because this was totally preventable.

The teaching is all about the potassium.

And you have to have empathy because patients hate those pills.

They are huge, they taste salty, and they do upset the stomach.

Right.

But you have to explain the why.

You sit down and you tell her, the potassium protects your heart from the digoxin.

It's like a shield.

If you skip the potassium shield, the digoxin becomes a poison.

And maybe some practical tips.

Definitely.

Take the potassium with a full glass of water and with food to help the stomach.

Do not crush it if it's an extended release tablet.

And do not take it at the same time as antacids because they can block the absorption.

This case study really ties it all together perfectly.

It shows how the physiology, the drug mechanism, and the patient's own behavior all collide.

That's nursing in a nutshell.

It's not just memorizing digoxin is for heart failure.

It's realizing that a simple stomach ache might actually be a lethal arrhythmia waiting to happen because the patient skipped a supplement they didn't like.

We have covered a massive amount of ground today.

Let's do a really rapid fire recap just to seal all this in.

Let's do it.

Okay, one, heart failure.

The pump is weak.

We use digoxin to make it squeeze harder.

That's positive inotrope and beat slower negative chronotrope.

The biggest risk is toxicity, which is almost always triggered by low potassium.

Watch for those halos.

Two, Ingenia.

The heart needs more oxygen.

It's a supply and demand problem.

We use nitrates to vasodilate watch for the headache and the hypotension.

Use beta blockers to slow the heart's domain, but don't stop them abruptly.

And we use CCBs for spasms.

Three, dysrhythmias.

The electricity is wrong.

We use sodium blockers, beta blockers, potassium channel blockers like amiodarone.

We have to watch the lungs and calcium blockers.

But always be careful because they can all cause new arrhythmias.

And for the students listening, remember the safety checks.

Apical pulse for a full 60 seconds, blood pressure before you give nitrates, and checking those potassium levels before you even think about giving digoxin.

Those are the safety nets.

If you use them every single time, keep your patients safe.

This has been a true deep dive into chapter 40.

We really hope this makes the big three feel a little less intimidating and a lot more logical.

Absolutely.

Read the charts in the book, look at the specific dosages, but keep these mechanisms in your head.

That's what matters on the floor.

Thanks for listening.

This is the Last Minute Lecture Team signing off.

Stay safe out there.